Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boca Raton, FL
SEC filing record 1 source field available
Fiscal year end
31 December
TherapeuticsMD, Inc. has filed 1,173 SEC EDGAR filings since 16 Aug 1995

SEC filing history

Showing 1-25 of 960 matching filings.

Per page
25
Current page
1
10-Q File 001-00100

QUARTERLY REPORT

Filing date
12 May 2026
Reporting date
31 Mar 2026
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
12 May 2026
Reporting date
02 May 2026
Next action
Verify source filing
SCHEDULE 13G File 005-32384

SCHEDULE 13G filing

Filing date
06 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-00100

ANNUAL REPORT

Filing date
01 Apr 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
NT 10-K File 001-00100

NOTIFICATION OF LATE FILING

Filing date
01 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
30 Mar 2026
Reporting date
30 Mar 2026
Next action
Verify source filing
10-K File 001-00100

ANNUAL REPORT

Filing date
30 Mar 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
21 Jan 2026
Reporting date
15 Jan 2026
Next action
Verify source filing
4

4 filing

Filing date
29 Dec 2025
Reporting date
23 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
16 Dec 2025
Reporting date
15 Dec 2025
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
13 Nov 2025
Reporting date
12 Nov 2025
Next action
Verify source filing
10-Q File 001-00100

QUARTERLY REPORT

Filing date
12 Nov 2025
Reporting date
30 Sep 2025
Next action
Verify source filing
4

4 filing

Filing date
05 Nov 2025
Reporting date
03 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Nov 2025
Reporting date
03 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Nov 2025
Reporting date
03 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Nov 2025
Reporting date
03 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-00100

ARS

Filing date
03 Nov 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-00100

PROXY STATEMENT

Filing date
03 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-00100

PROXY STATEMENT

Filing date
03 Nov 2025
Reporting date
15 Dec 2025
Next action
Verify source filing
PRE 14A File 001-00100

PROXY STATEMENT

Filing date
24 Oct 2025
Reporting date
24 Oct 2025
Next action
Verify source filing
10-Q File 001-00100

QUARTERLY REPORT

Filing date
12 Aug 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
12 Aug 2025
Reporting date
12 Aug 2025
Next action
Verify source filing
10-Q File 001-00100

QUARTERLY REPORT

Filing date
13 May 2025
Reporting date
31 Mar 2025
Next action
Verify source filing
8-K File 001-00100

CURRENT REPORT

Filing date
13 May 2025
Reporting date
13 May 2025
Next action
Verify source filing
10-K/A File 001-00100

AMENDMENT NO. 1 TO FORM 10-K

Filing date
30 Apr 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .